Home NDC 0299-3822 ORACEA
Product NDC 0299-3822
11-digit product format 002993822
Labeler code 0299
Product ID 0299-3822_67eef1b6-593a-4277-abd3-f3e60e7557b0
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DOXYCYCLINE
Dosage form CAPSULE
Route ORAL
Labeler Galderma Laboratories, L.P.
Application NDA050805
Marketing category NDA
Marketing start 2010-05-14
Substance DOXYCYCLINE
Active strength 40 mg/1
Pharmacologic classes Tetracycline-class Drug [EPC], Tetracyclines [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050805-001 ORACEA DOXYCYCLINE 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N050805-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N050805-001 7749532 2027-12-19 U-1063 Drug product
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050805-001 ORACEA 40MG CAPSULE / ORAL AB RLD, RS 2006-05-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N050805-001 ORACEA 40MG CAPSULE / ORAL RLD, RS 2006-05-26 f41ea6bd6efb…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 8 · 312 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N050805-001 7749532 2027-12-19 U-1063 Drug product 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050805-001 7749532 2027-12-19 U-1063 Drug product caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050805-001 7749532 2027-12-19 U-1063 Drug product 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050805-001 8206740 2025-12-24 U-925 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050805-001 7749532 2027-12-19 U-1063 Drug product 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050805-001 8206740 2025-12-24 U-925 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N050805-001 7749532 2027-12-19 U-1063 Drug product 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050805-001 8206740 2025-12-24 U-925 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050805-001 7749532 2027-12-19 U-1063 Drug product fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050805-001 8206740 2025-12-24 U-925 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050805-001 7749532 2027-12-19 U-1063 Drug product b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 8394405 2024-04-07 U-925 Drug product 2013-03-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 8394406 2024-04-07 U-925 Drug product 2013-03-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 8470364 2024-04-07 U-925 Drug product 2013-06-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 8709478 2024-04-07 U-1063 2014-04-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 8206740 2025-12-24 U-925 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050805-001 7749532 2027-12-19 U-1063 Drug product 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 8394405 2024-04-07 U-925 Drug product 2013-03-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 8394406 2024-04-07 U-925 Drug product 2013-03-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 8470364 2024-04-07 U-925 Drug product 2013-06-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 8709478 2024-04-07 U-1063 2014-04-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 8206740 2025-12-24 U-925 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050805-001 7749532 2027-12-19 U-1063 Drug product 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 8394405 2024-04-07 U-925 Drug product 2013-03-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 8394406 2024-04-07 U-925 Drug product 2013-03-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 8470364 2024-04-07 U-925 Drug product 2013-06-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 8709478 2024-04-07 U-1063 2014-04-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 8206740 2025-12-24 U-925 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050805-001 7749532 2027-12-19 U-1063 Drug product 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 8394405 2024-04-07 U-925 Drug product 2013-03-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 8394406 2024-04-07 U-925 Drug product 2013-03-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 8470364 2024-04-07 U-925 Drug product 2013-06-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 8709478 2024-04-07 U-1063 2014-04-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 8206740 2025-12-24 U-925 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050805-001 7749532 2027-12-19 U-1063 Drug product d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050805-001 8394405 2024-04-07 U-925 Drug product 2013-03-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N050805-001 8394406 2024-04-07 U-925 Drug product 2013-03-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N050805-001 8470364 2024-04-07 U-925 Drug product 2013-06-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N050805-001 8709478 2024-04-07 U-1063 2014-04-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N050805-001 8206740 2025-12-24 U-925 Drug product d06236e962d9…
Additional Listing Data#
Finished product Yes
Brand name base ORACEA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DOXYCYCLINE 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination N12000U13O Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 901399 Internal RxNorm lookup 901401 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded DOXYCYCLINE ACTIVE INGREDIENT N12000U13O ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 DOXYCYCLINE ANHYDROUS ACTIVE MOIETY 334895S862 ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A INACTIVE INGREDIENT NX76LV5T8J ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 SUCROSE INACTIVE INGREDIENT C151H8M554 ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 TALC INACTIVE INGREDIENT 7SEV7J4R1U ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10 TRIETHYL CITRATE INACTIVE INGREDIENT 8Z96QXD6UM ORACEA (DOXYCYCLINE) CAPSULE, DELAYED RELEASE [GALDERMA LABORATORIES, L.P.] 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0299-3822 ORACEA (DOXYCYCLINE) CAPSULE [GALDERMA LABORATORIES, L.P.] 19 Current NDC, Legacy NDC, 10 package rows 20250417_aa15c93a-ff4c-447a-8a21-96da506d8997.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0299-3822-02 00299382202 12 TRAY in 1 BOX (0299-3822-02) > 8 CARTON in 1 TRAY > 1 BLISTER PACK in 1 CARTON > 2 CAPSULE in 1 BLISTER PACK 12 tray 2015-02-01 0000-00-00 No No Current 0299-3822-04 00299382204 4 CAPSULE in 1 BLISTER PACK (0299-3822-04) 4 capsule 2010-05-14 0000-00-00 No No Current 0299-3822-05 00299382205 8 BLISTER PACK in 1 PACKAGE (0299-3822-05) > 4 CAPSULE in 1 BLISTER PACK 8 blister pack 2010-05-14 0000-00-00 No No Current 0299-3822-06 00299382206 16 KIT in 1 BOX (0299-3822-06) > 1 BLISTER PACK in 1 KIT > 4 CAPSULE in 1 BLISTER PACK 16 kit 2010-05-14 0000-00-00 No No Current 0299-3822-07 00299382207 24 TRAY in 1 BOX (0299-3822-07) > 4 CARTON in 1 TRAY > 1 BLISTER PACK in 1 CARTON > 2 CAPSULE in 1 BLISTER PACK 24 tray 2015-02-01 0000-00-00 No No Current 0299-3822-30 00299382230 30 CAPSULE in 1 BOTTLE (0299-3822-30) 30 capsule 2010-05-14 0000-00-00 No No Current